Regulating pharmaceutical companies' financial largesse.

about

Regulating pharmaceutical companies' financial largesse.

Item

http://www.wikidata.org/entity/Q55359165

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Regulating pharmaceutical companies' financial largesse.

@en

Regulating pharmaceutical companies' financial largesse.

@nl

type

Item

label

Regulating pharmaceutical companies' financial largesse.

@en

Regulating pharmaceutical companies' financial largesse.

@nl

prefLabel

Regulating pharmaceutical companies' financial largesse.

@en

Regulating pharmaceutical companies' financial largesse.

@nl

P1476

Regulating pharmaceutical companies' financial largesse

@en

P2093

Charles Silver

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development

The growth of physician medical malpractice payments: evidence from the National Practitioner Data Bank.

Use of Nondisclosure Agreements in Medical Malpractice Settlements by a Large Academic Health Care System.

Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation

The Role of Information in Medical Markets: An Analysis of Publicly Reported Outcomes in Cardiac Surgery.

P2888

s13584-018-0220-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13584-018-0220-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ronen Avraham

P577

2018-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29759077

http://www.w3.org/2001/XMLSchema#string

P932

5952623

http://www.w3.org/2001/XMLSchema#string